Key result
Synthetic glycerol backbone-based cationic lipids demonstrated transfection efficiency superior or parallel to that of two commercial transfection agents.
Authors
Loading...
May advance non-viral gene delivery tools; leaves open cardiovascular translation pending in vivo validation.
Liu et al. (2008) studied this question. Glycerol backbone-based cationic lipids vs. Commercial transfection agents was evaluated on Transfection efficiency. Synthetic glycerol backbone-based cationic lipids demonstrated transfection efficiency superior or parallel to that of two commercial transfection agents.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: